• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-016
Device Problems Retraction Problem (1536); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/13/2018
Event Type  Injury  
Event Description
On (b)(6) 2018, a 16mm amplatzer septal occluder (aso) and 7f amplatzer torqvue 45 delivery system were selected.During deployment, the device formed into a cobra shape and was difficult to resheath.A 9f amplatzer torqvue exchange system was used to remove the 16mm aso.A second 16mm aso was used to successfully complete the procedure.The patient did not any adverse consequences.Additional information has been requested.
 
Manufacturer Narrative
The reported event of deformity upon deployment and difficulty resheathing could not be confirmed.The investigation confirmed the device met functional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported event remains unknown.
 
Event Description
On (b)(6) 2018, a 16mm amplatzer septal occluder (aso) and 7f amplatzer torqvue 45 delivery system (dtv45) were selected.During deployment, the device formed into a cobra shape and was difficult to resheath.A 9f amplatzer torqvue exchange system (etv) was used to remove the 16mm aso.A second 16mm aso was deployed using the original dtv45 delivery cable through the 9f etv to successfully complete the procedure.Per report the procedure was extended by 36 minutes.The patient did not have any adverse consequences and was discharged the next day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key7932871
MDR Text Key122620914
Report Number2135147-2018-00171
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010137
UDI-Public00811806010137
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Model Number9-ASD-016
Device Catalogue Number9-ASD-016
Device Lot Number6330307
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/08/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/13/2018
Initial Date FDA Received10/03/2018
Supplement Dates Manufacturer Received11/13/2018
Supplement Dates FDA Received12/02/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/21/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age2 YR
Patient Weight9
-
-